Editorial: evolution of GLP‐1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity – authors’ reply

LINKED CONTENT This article is linked to Flint et al papers. To view these articles, visit https://doi.org/10.1111/apt.16608 and https://doi.org/10.1111/apt.16641

Saved in:
Bibliographic Details
Published inAlimentary pharmacology & therapeutics Vol. 54; no. 11-12; p. 1498
Main Authors Flint, Anne, Andersen, Grit, Hockings, Paul, Plum‐Mörschel, Leona, Loomba, Rohit
Format Journal Article
LanguageEnglish
Published Chichester Wiley Subscription Services, Inc 01.12.2021
Subjects
Diabetes mellitus
Drug therapy
Online AccessGet full text

Cover

More Information
Summary:LINKED CONTENT This article is linked to Flint et al papers. To view these articles, visit https://doi.org/10.1111/apt.16608 and https://doi.org/10.1111/apt.16641
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ObjectType-Article-3
ISSN:0269-2813
1365-2036
1365-2036
DOI:10.1111/apt.16669